172 related articles for article (PubMed ID: 28906339)
1. Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features.
Perez-Lopez R; Nava Rodrigues D; Figueiredo I; Mateo J; Collins DJ; Koh DM; de Bono JS; Tunariu N
Invest Radiol; 2018 Feb; 53(2):96-102. PubMed ID: 28906339
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.
Perez-Lopez R; Mateo J; Mossop H; Blackledge MD; Collins DJ; Rata M; Morgan VA; Macdonald A; Sandhu S; Lorente D; Rescigno P; Zafeiriou Z; Bianchini D; Porta N; Hall E; Leach MO; de Bono JS; Koh DM; Tunariu N
Radiology; 2017 Apr; 283(1):168-177. PubMed ID: 27875103
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer.
Donners R; Figueiredo I; Westaby D; Koh DM; Tunariu N; Carreira S; de Bono JS; Fotiadis N
Cancer Imaging; 2023 Dec; 23(1):121. PubMed ID: 38102655
[TBL] [Abstract][Full Text] [Related]
5. Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases.
Donners R; Candito A; Blackledge M; Rata M; Messiou C; Koh DM; Tunariu N
Br J Radiol; 2023 Nov; 96(1151):20230378. PubMed ID: 37660399
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing.
Donners R; Figueiredo I; Tunariu N; Blackledge M; Koh DM; de la Maza MLDF; Chandran K; de Bono JS; Fotiadis N
Eur Radiol; 2022 Jul; 32(7):4647-4656. PubMed ID: 35092476
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
[TBL] [Abstract][Full Text] [Related]
9. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.
Anzidei M; Napoli A; Sacconi B; Boni F; Noce V; Di Martino M; Saba L; Catalano C
Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615
[TBL] [Abstract][Full Text] [Related]
11. MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
Wang Y; Yu B; Zhong F; Guo Q; Li K; Hou Y; Lin N
Magn Reson Imaging; 2019 Jul; 60():76-84. PubMed ID: 30917943
[TBL] [Abstract][Full Text] [Related]
12. Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.
Tamada T; Sone T; Kanomata N; Miyaji Y; Kido A; Jo Y; Yamamoto A; Ito K
J Magn Reson Imaging; 2016 Sep; 44(3):584-93. PubMed ID: 26872679
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis.
Wetter A; Lipponer C; Nensa F; Heusch P; Rübben H; Schlosser TW; Pöppel TD; Lauenstein TC; Nagarajah J
Ann Nucl Med; 2014 Jun; 28(5):405-10. PubMed ID: 24595461
[TBL] [Abstract][Full Text] [Related]
15. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
16. Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect?
Yachida Y; Yoshida S; Takeshita H; Sawamura C; Tanaka H; Satoh S; Uchida Y; Ishioka J; Matsuoka Y; Numao N; Koga F; Saito K; Fujii Y; Kihara K
Urol Int; 2014; 93(2):170-5. PubMed ID: 24732031
[TBL] [Abstract][Full Text] [Related]
17. Texture analysis of apparent diffusion coefficient maps for treatment response assessment in prostate cancer bone metastases-A pilot study.
Reischauer C; Patzwahl R; Koh DM; Froehlich JM; Gutzeit A
Eur J Radiol; 2018 Apr; 101():184-190. PubMed ID: 29571795
[TBL] [Abstract][Full Text] [Related]
18. Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.
Padhani AR; van Ree K; Collins DJ; D'Sa S; Makris A
AJR Am J Roentgenol; 2013 Jan; 200(1):163-70. PubMed ID: 23255758
[TBL] [Abstract][Full Text] [Related]
19. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
Nketiah G; Elschot M; Kim E; Teruel JR; Scheenen TW; Bathen TF; Selnæs KM
Eur Radiol; 2017 Jul; 27(7):3050-3059. PubMed ID: 27975146
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of the apparent diffusion coefficient value of metastatic bone tumours on diffusion-weighted MRI images: differences according to the types of primary tumour, the affected bones, and clinical factors.
Cha MJ; Yoon YC
Clin Radiol; 2015 Oct; 70(10):1116-21. PubMed ID: 26145186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
